^
No biomarker
Thymic Carcinoma
lenvatinib
Sensitive
:
A1
No biomarker
Thymic Carcinoma
GEM-CAP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
LV5FU2
Sensitive
:
A2
No biomarker
Thymoma
GEM-CAP
Sensitive
:
A2
No biomarker
Thymoma
LV5FU2
Sensitive
:
A2
No biomarker
Thymic Carcinoma
CaT
Sensitive
:
A2
No biomarker
Thymoma
CaT
Sensitive
:
A2
KIT mutation
Thymic Carcinoma
sunitinib
Sensitive
:
A2
No biomarker
Thymoma
VIP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
VIP
Sensitive
:
A2
No biomarker
Thymoma
CAP
Sensitive
:
A2
No biomarker
Thymoma
etoposide IV
Sensitive
:
A2
No biomarker
Thymoma
ifosfamide
Sensitive
:
A2
No biomarker
Thymic Carcinoma
EP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
ADOC
Sensitive
:
A2
No biomarker
Thymic Carcinoma
CAP + prednisone
Sensitive
:
A2
No biomarker
Thymic Carcinoma
CAP
Sensitive
:
A2
No biomarker
Thymoma
CAP + prednisone
Sensitive
:
A2
No biomarker
Thymoma
ADOC
Sensitive
:
A2
No biomarker
Thymoma
EP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
carboplatin
Sensitive
:
A2
No biomarker
Thymic Carcinoma
paclitaxel
Sensitive
:
A2
No biomarker
Thymoma
carboplatin
Sensitive
:
A2
No biomarker
Thymoma
pembrolizumab
Resistant
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our